| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
RileyMoore1 • Boone - Economics Honors - Spring 2023 (1st) • Mar 2023
Closing position
TV7 • Aalto Investments game (Fall 2022) • Oct 2022
As the fund's policy says.
Deep_Value • Aalto Investments game (Fall 2022) • Oct 2022
Strong uptrend. We follow the momentum
MLP_SAMA • Millennium Summer Challenge (2022) • Aug 2022
Rallied 30% in 2022 and boosted after Q2 earnings - momentum trade - MR Pharmaceuticals bond proxy
TeamBond • Aalto Investment management game (Fall 2021) • Nov 2021
Creating portfolio healthcare industries, long position. Followed last year's performance and expectations for next year. Following my investment strategy.
LiisaNa • Aalto Investment management game (Fall 2021) • Nov 2021
Belongs to our Healthcare sector and Medium P/E group with a P/E of 23,32.
The stocks were selected based on their earnings, growth potential and risk of financial distress. These factors were determined by the company’s P/E-ratios, growth estimates and the strength of their financial positions.
Berlino • Aalto Investment management game (Fall 2021) • Nov 2021
The market is currently undervaluing this stock by over 50%. We decided to go long as there are great margins of profitability in the long run.
aharbinson83 • Starting Small • Sep 2021
Motley fool down 33pc after 2 failed trials but market leader on cystic fibrosis drugs